In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GeneProt Inc.

www.geneprot.com

Latest From GeneProt Inc.

Cellzome GMBH

Cellzome is the first biotechnology company founded on the EMBL campus in Heidelberg. With proprietary proteomics platforms developed at the EMBL, Cellzome will apply its technology on a large scale for target discovery, validation and drug development.
BioPharmaceutical

GeneProt Inc.

Boasting an impressive group of scientific founders, 17-month-old GeneProt Inc. has raised $122 million from a variety of institutional and corporate sources. With that money, it has built what the company touts as the first large-scale proteomics discovery and production facility. It hopes to leverage that firepower into a variety of revenue sources including the sale of novel therapeutics to pharmaceutical company sponsors.
BioPharmaceutical Strategy

Start-Up Previews (7/01)

A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile groups focus on Biorepositories (Asterand Inc., BioSample Inc., Genomics Collaborative Inc., TissueInformatics Inc.); Therapeutics for Diabetes and Obesity (Arexis AB, Diabetogen Biosciences Inc., PanCel Corp., Rademacher Group Ltd.); and Orthopedic and Surgical Devices (Ascension Orthopedics Inc., Coapt Systems Inc., NuVasive Inc., SpringFlex Orthopedics Inc.). Plus these Selected Start-Ups across Health Care: Achillion Pharmaceuticals Inc., GeneProt Inc., MonitorForHire.com and Targacept Inc.
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Bioinformatics
    • Large Molecule
    • Synthesis Technologies, Production Processes
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Geneva Proteomics Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • GeneProt Inc.
  • Senior Management
  • Bertrand Damour, CEO & CFO
    Robin Offord , PhD, Pres.
    Ranald Sutherland, PhD, VP, Bus. Dev.
  • Contact Info
  • GeneProt Inc.
    Phone: (732) 246-8950
    1031 US Hwy. 22
    Ste. 302
    Bridgewater, NJ 08807
    USA
UsernamePublicRestriction

Register